Clinical Trial: Prospective Evaluation of Diagnostic Performance of PanTum Detect Test in Adult Patients with Suspected or Confirmed Macroscopic Solid Pre-malignant or Malignant Lesion(s) Referred to Fludeoxyglucose (18F) PET/CT and in Adult Healthy Population

U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06842615) titled 'Prospective Evaluation of Diagnostic Performance of PanTum Detect Test in Adult Patients with Suspected or Confirmed Macroscopic Solid Pre-malignant or Malignant Lesion(s) Referred to Fludeoxyglucose (18F) PET/CT and in Adult Healthy Population' on Dec. 11, 2024.

Brief Summary: This prospective phase II trial aims to evaluate the diagnostic performance of multi-cancer epitope diagnosis in monocyte (EDIM) based blood test PanTum detect test for early detection of individuals with pre-malignant or malignant lesion(s).

The intervention in this trial is the PanTum detect test performed in two parallel groups of participants:

Group A:...